IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Royalty Pharma Sub-Manager, LLC

Portfolio Profile

CIK: 0002081668 | New York, NY

Investment Profile

Style

Deep Value

Turnover

Medium

Orientation

Concentrated trader
$241.9M
AUM
4
Positions
100%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Cytokinetics, Inc(CYTK)980,392$83.5M34.52%
2Zenas Biopharma, Inc.(ZBIO)2,388,150$60.6M25.05%
3Kailera Therapeutics(KLRA)2,455,357$54.1M22.36%
4Biohaven LTD(BHVN)2,936,507$43.7M18.06%

Sector Allocation

Latest filing, equity positions only

Healthcare77.64% · $187.8M
Unclassified22.36% · $54.1M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare100%77.64%-22.36%
Unclassified0%22.36%+22.36%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$171.3M | 4 pos.
$172.8M | 4 pos.
$241.9M | 4 pos.
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

1
New
1
Cap SizePrev %Curr %Change
Mid Cap72.98%52.59%-20.39%
Small Cap27.02%25.05%-1.97%
Unclassified0%22.36%+22.36%
Closed
0
Increased
0
Decreased
3
Unchanged